EC Number |
Inhibitors |
Structure |
---|
1.1.1.39 | phosphoenolpyruvate |
- |
|
1.1.1.39 | phosphoenolpyruvate |
activates at low concentrations, deactivation at high concentrations |
|
1.1.1.39 | pyruvate |
- |
|
1.1.1.39 | pyruvate |
product inhibition |
|
1.1.1.39 | pyruvate |
isozyme NAD-ME2, uncompetitive versus NAD+, mixed inhibition versus (S)-malate. Pyruvate inhibition is uncompetitive with respect to NAD+ and mixed with respect to (S)-malate for the chimeric mutant NAD-ME1q; pyruvate inhibition is uncompetitive with respect to NAD+ and mixed with respect to (S)-malate for the chimeric mutant NAD-ME1q |
|
1.1.1.39 | Tartrate |
- |
|
1.1.1.39 | Tartrate |
substrate analogue, isozyme NAD-ME2, uncompetitive versus NAD+, competitive versus (S)-malate |
|
1.1.1.39 | Tartronate |
- |
|
1.1.1.39 | Tartronate |
binding site structure at the active site, competitive |
|
1.1.1.39 | Urea |
denaturation, in 3-5 M urea, the enzyme undergoes a reversible tetramer-dimer-monomer quaternary structural change in an acidic pH environment, which resulted in a molten globule state that is prone to aggregate, Mn2+ protects, overview |
|